Skip to content
← Full study record

NCT01872819 · OUTCOME

Achievability of Performing Individualized Drug Screening and Initiating Therapy Based on the Results of the Drug Screen for Poor Risk Patients With Relapsed or Refractory AML

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · Source last updated 2018-07-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
days
Interval / dispersion
Full Range
Time frame
Up to 21 days

What was measured

Whether treatment was administered in the time frame based on the high throughput drug screen. Time from sample procurement to assay results.

Analysis population: 14 patients were treated.

Groups in this outcome

Treated Patients

14 patients were treated.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treated Patients14

Reported measurements

Source class 1
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Treated Patients5.1Not reported48Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        4
        upper Limit
        8
        value
        5.1
denoms
  1. counts
    1. group Id
      OG000
      value
      14
    units
    Participants
description
Whether treatment was administered in the time frame based on the high throughput drug screen. Time from sample procurement to assay results.
dispersion Type
Full Range
groups
  1. description
    14 patients were treated.
    id
    OG000
    title
    Treated Patients
param Type
MEDIAN
population Description
14 patients were treated.
reporting Status
POSTED
time Frame
Up to 21 days
title
Achievability of Performing Individualized Drug Screening and Initiating Therapy Based on the Results of the Drug Screen for Poor Risk Patients With Relapsed or Refractory AML
type
PRIMARY
unit Of Measure
days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice